APO Research
Talk to an analyst

APO RESEARCH · REPORT

ADC Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global ADC Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025183 pages

Choose your research edition.

Industry ResearchADC Drug Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal ADC Drug Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal ADC Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal ADC Drug Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal ADC Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global ADC Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for ADC Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for ADC Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for ADC Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for ADC Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of ADC Drug include RemeGen Co., Ltd., Roche, Gilead(Immunomedics), Pfizer Inc., AstraZeneca, Seagen, Rakuten Medical and ADC Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global ADC Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of ADC Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents ADC Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the ADC Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

ADC Drug Segment by Company

RemeGen Co., Ltd.

Roche

Gilead(Immunomedics)

Pfizer Inc.

AstraZeneca

Seagen

Rakuten Medical

ADC Therapeutics

ADC Drug Segment by Type

First Generation ADC Drug

Third Generation ADC Drug

Second Generation ADC Drug

ADC Drug Segment by Application

Leukemia

Lymphoma

Breast Cancer

Other

ADC Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global ADC Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of ADC Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of ADC Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the ADC Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of ADC Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of ADC Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of ADC Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. ADC Drug Industry Trends Table 2. ADC Drug Industry Drivers Table 3. ADC Drug Industry Opportunities and Challenges Table 4. ADC Drug Industry Restraints Table 5. Global ADC Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global ADC Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global ADC Drug Sales by Manufacturers (k units) & (2021-2026) Table 8. Global ADC Drug Sales Market Share by Manufacturers Table 9. Global ADC Drug Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global ADC Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global ADC Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global ADC Drug Manufacturers, Product Type & Application Table 13. Global ADC Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global ADC Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of First Generation ADC Drug Table 17. Major Manufacturers of Third Generation ADC Drug Table 18. Major Manufacturers of Second Generation ADC Drug Table 19. Global ADC Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global ADC Drug Sales by Type (2021-2026) & (k units) Table 21. Global ADC Drug Sales by Type (2027-2032) & (k units) Table 22. Global ADC Drug Sales Market Share by Type (2021-2026) Table 23. Global ADC Drug Sales Market Share by Type (2027-2032) Table 24. Global ADC Drug Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global ADC Drug Revenue by Type (2021-2026) & (k units) Table 26. Global ADC Drug Revenue by Type (2027-2032) & (k units) Table 27. Global ADC Drug Revenue Market Share by Type (2021-2026) Table 28. Global ADC Drug Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Leukemia Table 30. Major Manufacturers of Lymphoma Table 31. Major Manufacturers of Breast Cancer Table 32. Major Manufacturers of Other Table 33. Global ADC Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global ADC Drug Sales by Application (2021-2026) & (k units) Table 35. Global ADC Drug Sales by Application (2027-2032) & (k units) Table 36. Global ADC Drug Sales Market Share by Application (2021-2026) Table 37. Global ADC Drug Sales Market Share by Application (2027-2032) Table 38. Global ADC Drug Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global ADC Drug Revenue by Application (2021-2026) & (k units) Table 40. Global ADC Drug Revenue by Application (2027-2032) & (k units) Table 41. Global ADC Drug Revenue Market Share by Application (2021-2026) Table 42. Global ADC Drug Revenue Market Share by Application (2027-2032) Table 43. Global ADC Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global ADC Drug Sales by Region (2021-2026) & (k units) Table 45. Global ADC Drug Sales Market Share by Region (2021-2026) Table 46. Global ADC Drug Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global ADC Drug Sales Forecasted Market Share by Region (2027-2032) Table 48. North America ADC Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America ADC Drug Sales by Country (2021-2026) & (k units) Table 50. North America ADC Drug Sales by Country (2027-2032) & (k units) Table 51. Europe ADC Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe ADC Drug Sales by Country (2021-2026) & (k units) Table 53. Europe ADC Drug Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific ADC Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific ADC Drug Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific ADC Drug Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa ADC Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa ADC Drug Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa ADC Drug Sales by Country (2027-2032) & (k units) Table 60. Global ADC Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global ADC Drug Revenue by Region (2021-2026) & (US$ Million) Table 62. Global ADC Drug Revenue by Region (2027-2032) & (US$ Million) Table 63. Global ADC Drug Revenue Market Share by Region (2021-2026) Table 64. Global ADC Drug Revenue Market Share by Region (2027-2032) Table 65. RemeGen Co., Ltd. Company Information Table 66. RemeGen Co., Ltd. Business Overview Table 67. RemeGen Co., Ltd. ADC Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. RemeGen Co., Ltd. ADC Drug Product Portfolio Table 69. RemeGen Co., Ltd. Recent Development Table 70. Roche Company Information Table 71. Roche Business Overview Table 72. Roche ADC Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Roche ADC Drug Product Portfolio Table 74. Roche Recent Development Table 75. Gilead(Immunomedics) Company Information Table 76. Gilead(Immunomedics) Business Overview Table 77. Gilead(Immunomedics) ADC Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Gilead(Immunomedics) ADC Drug Product Portfolio Table 79. Gilead(Immunomedics) Recent Development Table 80. Pfizer Inc. Company Information Table 81. Pfizer Inc. Business Overview Table 82. Pfizer Inc. ADC Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Pfizer Inc. ADC Drug Product Portfolio Table 84. Pfizer Inc. Recent Development Table 85. AstraZeneca Company Information Table 86. AstraZeneca Business Overview Table 87. AstraZeneca ADC Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. AstraZeneca ADC Drug Product Portfolio Table 89. AstraZeneca Recent Development Table 90. Seagen Company Information Table 91. Seagen Business Overview Table 92. Seagen ADC Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Seagen ADC Drug Product Portfolio Table 94. Seagen Recent Development Table 95. Rakuten Medical Company Information Table 96. Rakuten Medical Business Overview Table 97. Rakuten Medical ADC Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Rakuten Medical ADC Drug Product Portfolio Table 99. Rakuten Medical Recent Development Table 100. ADC Therapeutics Company Information Table 101. ADC Therapeutics Business Overview Table 102. ADC Therapeutics ADC Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. ADC Therapeutics ADC Drug Product Portfolio Table 104. ADC Therapeutics Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. ADC Drug Distributors List Table 108. ADC Drug Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. ADC Drug Product Image Figure 2. Global ADC Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global ADC Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global ADC Drug Sales (2021-2032) & (k units) Figure 5. Global ADC Drug Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 ADC Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. First Generation ADC Drug Image Figure 9. Third Generation ADC Drug Image Figure 10. Second Generation ADC Drug Image Figure 11. Global ADC Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global ADC Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global ADC Drug Sales Market Share by Type (2021-2032) Figure 14. Global ADC Drug Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global ADC Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global ADC Drug Revenue Market Share by Type (2021-2032) Figure 17. Leukemia Image Figure 18. Lymphoma Image Figure 19. Breast Cancer Image Figure 20. Other Image Figure 21. Global ADC Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global ADC Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global ADC Drug Sales Market Share by Application (2021-2032) Figure 24. Global ADC Drug Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global ADC Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global ADC Drug Revenue Market Share by Application (2021-2032) Figure 27. North America ADC Drug Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America ADC Drug Sales Market Share by Country (2021-2032) Figure 29. U.S. ADC Drug Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada ADC Drug Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico ADC Drug Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe ADC Drug Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe ADC Drug Sales Market Share by Country (2021-2032) Figure 34. Germany ADC Drug Sales and Growth Rate (2021-2032) & (k units) Figure 35. France ADC Drug Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. ADC Drug Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy ADC Drug Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands ADC Drug Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific ADC Drug Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific ADC Drug Sales Market Share by Country (2021-2032) Figure 41. China ADC Drug Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan ADC Drug Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea ADC Drug Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia ADC Drug Sales and Growth Rate (2021-2032) & (k units) Figure 45. India ADC Drug Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia ADC Drug Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa ADC Drug Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa ADC Drug Sales Market Share by Country (2021-2032) Figure 49. Brazil ADC Drug Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa ADC Drug Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia ADC Drug Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey ADC Drug Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina ADC Drug Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE ADC Drug Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt ADC Drug Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile ADC Drug Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global ADC Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global ADC Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America ADC Drug Revenue (2021-2032) & (US$ Million) Figure 60. North America ADC Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe ADC Drug Revenue (2021-2032) & (US$ Million) Figure 62. Europe ADC Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific ADC Drug Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific ADC Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa ADC Drug Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa ADC Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. ADC Drug Value Chain Figure 68. Manufacturing Cost Structure Figure 69. ADC Drug Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • First Generation ADC Drug
  • Third Generation ADC Drug
  • Second Generation ADC Drug
Applications
  • Leukemia
  • Lymphoma
  • Breast Cancer
  • Other
Companies covered
  • RemeGen Co., Ltd.
  • Roche
  • Gilead(Immunomedics)
  • Pfizer Inc.
  • AstraZeneca
  • Seagen
  • Rakuten Medical
  • ADC Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global ADC Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global ADC Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global ADC Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global ADC Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global ADC Drug Market Dynamics
  1. 2.1 ADC Drug Industry Trends
  2. 2.2 ADC Drug Industry Drivers
  3. 2.3 ADC Drug Industry Opportunities and Challenges
  4. 2.4 ADC Drug Industry Restraints
3 ADC Drug Market by Manufacturers
  1. 3.1 Global ADC Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global ADC Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global ADC Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global ADC Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global ADC Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global ADC Drug Manufacturers, Product Type & Application
  7. 3.7 Global ADC Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global ADC Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 ADC Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 ADC Drug Tier 1, Tier 2, and Tier 3
4 ADC Drug Market by Type
  1. 4.1 ADC Drug Type Introduction
  2. 4.1.1 First Generation ADC Drug
  3. 4.1.2 Third Generation ADC Drug
  4. 4.1.3 Second Generation ADC Drug
  5. 4.2 Global ADC Drug Sales by Type
  6. 4.2.1 Global ADC Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global ADC Drug Sales by Type (2021-2032)
  8. 4.2.3 Global ADC Drug Sales Market Share by Type (2021-2032)
  9. 4.3 Global ADC Drug Revenue by Type
  10. 4.3.1 Global ADC Drug Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global ADC Drug Revenue by Type (2021-2032)
  12. 4.3.3 Global ADC Drug Revenue Market Share by Type (2021-2032)
5 ADC Drug Market by Application
  1. 5.1 ADC Drug Application Introduction
  2. 5.1.1 Leukemia
  3. 5.1.2 Lymphoma
  4. 5.1.3 Breast Cancer
  5. 5.1.4 Other
  6. 5.2 Global ADC Drug Sales by Application
  7. 5.2.1 Global ADC Drug Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global ADC Drug Sales by Application (2021-2032)
  9. 5.2.3 Global ADC Drug Sales Market Share by Application (2021-2032)
  10. 5.3 Global ADC Drug Revenue by Application
  11. 5.3.1 Global ADC Drug Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global ADC Drug Revenue by Application (2021-2032)
  13. 5.3.3 Global ADC Drug Revenue Market Share by Application (2021-2032)
6 Global ADC Drug Sales by Region
  1. 6.1 Global ADC Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global ADC Drug Sales by Region (2021-2032)
  3. 6.2.1 Global ADC Drug Sales by Region (2021-2026)
  4. 6.2.2 Global ADC Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America ADC Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America ADC Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe ADC Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe ADC Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific ADC Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific ADC Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa ADC Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa ADC Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global ADC Drug Revenue by Region
  1. 7.1 Global ADC Drug Revenue by Region
  2. 7.1.1 Global ADC Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global ADC Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global ADC Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global ADC Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America ADC Drug Revenue (2021-2032)
  8. 7.2.2 North America ADC Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe ADC Drug Revenue (2021-2032)
  11. 7.3.2 Europe ADC Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific ADC Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific ADC Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa ADC Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa ADC Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 RemeGen Co., Ltd.
  2. 8.1.1 RemeGen Co., Ltd. Company Information
  3. 8.1.2 RemeGen Co., Ltd. Business Overview
  4. 8.1.3 RemeGen Co., Ltd. ADC Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 RemeGen Co., Ltd. ADC Drug Product Portfolio
  6. 8.1.5 RemeGen Co., Ltd. Recent Developments
  7. 8.2 Roche
  8. 8.2.1 Roche Company Information
  9. 8.2.2 Roche Business Overview
  10. 8.2.3 Roche ADC Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Roche ADC Drug Product Portfolio
  12. 8.2.5 Roche Recent Developments
  13. 8.3 Gilead(Immunomedics)
  14. 8.3.1 Gilead(Immunomedics) Company Information
  15. 8.3.2 Gilead(Immunomedics) Business Overview
  16. 8.3.3 Gilead(Immunomedics) ADC Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Gilead(Immunomedics) ADC Drug Product Portfolio
  18. 8.3.5 Gilead(Immunomedics) Recent Developments
  19. 8.4 Pfizer Inc.
  20. 8.4.1 Pfizer Inc. Company Information
  21. 8.4.2 Pfizer Inc. Business Overview
  22. 8.4.3 Pfizer Inc. ADC Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Inc. ADC Drug Product Portfolio
  24. 8.4.5 Pfizer Inc. Recent Developments
  25. 8.5 AstraZeneca
  26. 8.5.1 AstraZeneca Company Information
  27. 8.5.2 AstraZeneca Business Overview
  28. 8.5.3 AstraZeneca ADC Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 AstraZeneca ADC Drug Product Portfolio
  30. 8.5.5 AstraZeneca Recent Developments
  31. 8.6 Seagen
  32. 8.6.1 Seagen Company Information
  33. 8.6.2 Seagen Business Overview
  34. 8.6.3 Seagen ADC Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Seagen ADC Drug Product Portfolio
  36. 8.6.5 Seagen Recent Developments
  37. 8.7 Rakuten Medical
  38. 8.7.1 Rakuten Medical Company Information
  39. 8.7.2 Rakuten Medical Business Overview
  40. 8.7.3 Rakuten Medical ADC Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Rakuten Medical ADC Drug Product Portfolio
  42. 8.7.5 Rakuten Medical Recent Developments
  43. 8.8 ADC Therapeutics
  44. 8.8.1 ADC Therapeutics Company Information
  45. 8.8.2 ADC Therapeutics Business Overview
  46. 8.8.3 ADC Therapeutics ADC Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 ADC Therapeutics ADC Drug Product Portfolio
  48. 8.8.5 ADC Therapeutics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 ADC Drug Value Chain Analysis
  2. 9.1.1 ADC Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 ADC Drug Production Mode & Process
  6. 9.2 ADC Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 ADC Drug Distributors
  9. 9.2.3 ADC Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst